Collaboration with BD adds significant new asset to medtech development ecosystem in Atlanta and the southeast. Media Release – February 28, 2017 (Atlanta, Ga.) – The Global Center for Medical Innovation (GCMI) announced today it is partnering with BD (Becton, Dickinson and Company) to support the launch of, and the first startup to enter, the…
GCMI and T3 Labs CEO Tiffany Wilson shares insights with Assembly Magazine on what it takes to bring a medical device from concept to commercialization. Developing a new medical technology is not for the faint of heart. It is a daunting, expensive, arduous process, but nevertheless, it is highly rewarding. The developmental pathway is enough…
Pediatrics 2040 (Peds2040) is the annual meeting hosted by the international Society for Pediatric Innovation (iSPI). The conference connects clinical specialists, entrepreneurs, industry leaders and allied healthcare professionals committed to bettering patient outcomes in pediatrics. In attending PEDS2040 GCMI/T3 Labs was given a unique opportunity to be surrounded by the whole of the pediatric innovation…
GCMI and T3 Labs are proud of our CEO Tiffany Wilson and the commitment and fervor she brings to the medical device community. Recently, Tiffany was recognized as one of Inc.’s “17 inspiring women to watch in 2017.” Each woman spotlighted is an exemplar of leadership and tenacity: acting as a driving force for their…
2016 was a fantastic year for the Global Center for Medical Innovation (GCMI) and for the medical technology community as a whole. This year has been characterized by its spirit of collaboration, and the industry’s determination to meet and create new goals for medtech innovation. It is with fervor and excitement that we carry the…
Having a facility like T3 to test novel and breakthrough applications’ ability to save lives is crucial for battling diseases and disorders. Dr. Matheny and the original team of T3 recognized the need and saw to it that it was met. The change in landscape for innovators was born from desperation and a desire to…
GCMI and T3 Labs CEO Tiffany Wilson shares medtech development pathway insights in Medical Product Outsourcing. Bringing a new medical device from concept to cure to commercialization is an intimidating, complex and expensive process which often stifles innovation instead of encouraging it. Yet there remains a tremendous need and viable markets for medtech innovation…
For medical product innovators large and small, T3 Labs prides itself on delivering the highest value preclinical testing and bioskills training services available. Once Bio2 Technologies reached the second stage in the process from concept to cure to commercialization – preclinical – they entrusted T3 Labs to deliver three consecutive studies for the first completely…
The Masters of Biomedical Innovation and Development program (BioID program) is a collaborative academic experience in Biomedical technology and a hands-on clinical experience built upon the extraordinary resources and reputation of the Wallace H. Coulter Department of Biomedical Engineering: a joint department of the Georgia Tech College of Engineering and the Emory University School of Medicine.…
The Cardiovascular Research Foundation’s annual TCT conference serves as the premier cardiovascular event of the year: delivering the latest clinical and preclinical updates on a wide spectrum of transcatheter therapies and the 2016 edition was no exception. In addition to catching up with existing and prospective sponsors and FDA regulators, here are a few of…